Literature DB >> 1311401

The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa.

Z Hochberg1, P Hertz, V Colin, S Ish-Shalom, D Yeshurun, M B Youdim, T Amit.   

Abstract

The endocrine abnormalities along the growth hormone (GH) axis in anorexia nervosa (AN) and in obesity include hypothalamic, pituitary, and peripheral elements. The present study was undertaken to evaluate the effects of these nutritional extremes on GH-binding protein (BP) levels and on Insulin-like growth factor-I (IGF-I) receptors on red blood cells (RBC). Nine patients with AN and 20 obese subjects were compared with normal control children, adolescents, and adults. GH-BP was measured by a binding assay with dextran-coated charcoal separation. IGF-I binding was measured on enriched RBC. Serum GH-BP levels were markedly reduced in the AN patients, and highly increased in the obese. Scatchard analyses showed linear plots with unaltered binding affinities (Ka). The binding capacity (Bmax) was significantly lower than normal control in the AN patients and higher in the obese. GH-BP levels correlated positively with the body mass index (BMI). RBC [125I]IGF-I binding was significantly elevated in the AN patients and low in the obese. Scatchard analyses showed curvilinear plots. The high-affinity constants (Ka1) were slightly, but significantly, higher in the AN patients and in the obese compared with control. The binding capacity of the first binder (Bmax1) was lower in obesity than in AN or control. The low-affinity constants (Ka2) were similar in the three groups, and its binding capacity (Bmax2) was similar in the AN patients and the controls, but significantly lower in the obese. [125I]IGF-I binding correlated negatively and significantly with the BMI and with the GH-BP.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311401     DOI: 10.1016/0026-0495(92)90198-j

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  22 in total

Review 1.  Associated factors for accelerated growth in childhood: a systematic review.

Authors:  Maria Aurora Chrestani; Iná S Santos; Bernardo L Horta; Samuel C Dumith; Maria Alice Souza de Oliveira Dode
Journal:  Matern Child Health J       Date:  2013-04

2.  Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.

Authors:  G Grugni; G Guzzaloni; F Morabito
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

Review 3.  Circulating growth hormone binding proteins.

Authors:  G Baumann; M A Shaw; K Amburn
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

4.  Relation between insulin-like growth factor-I, body mass index, and clinical status in cystic fibrosis.

Authors:  A M Taylor; A Bush; A Thomson; P J Oades; J L Marchant; C Bruce-Morgan; J Holly; L Ahmed; D B Dunger
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

5.  Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity.

Authors:  S E Oleandri; M Maccario; R Rossetto; M Procopio; S Grottoli; E Avogadri; C Gauna; C Ganzaroli; E Ghigo
Journal:  J Endocrinol Invest       Date:  1999-02       Impact factor: 4.256

6.  Effects of rhIGF-I administration on bone turnover during short-term fasting.

Authors:  S K Grinspoon; H B Baum; S Peterson; A Klibanski
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

7.  Identification of four chromosomal loci determining obesity in a multifactorial mouse model.

Authors:  C H Warden; J S Fisler; S M Shoemaker; P Z Wen; K L Svenson; M J Pace; A J Lusis
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 8.  Insulin and insulin-like growth factors in diabetes mellitus.

Authors:  D B Dunger
Journal:  Arch Dis Child       Date:  1995-06       Impact factor: 3.791

9.  Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with type 1 (insulin-dependent) diabetes mellitus.

Authors:  G Massa; L Dooms; R Bouillon; M Vanderschueren-Lodeweyckx
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

10.  Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications.

Authors:  J D Veldhuis; M L Johnson; L M Faunt; M Mercado; G Baumann
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.